Sintx Technologies (SINT) AI Stock Analysis

• Market Cap: $5.23M
• Dividend Yield: N/A
• Average Volume (3M): 93.38K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.61
• Revenue Growth: 9.90%
• EPS Growth: 94.56%
• Country: US
• Employees: 20
• Sector: Healthcare
• Sector Strength: 74
• Industry: Medical - Devices
• EPS (TTM): -22.09
• Shares Outstanding: 2,515,179
• 10 Day Avg. Volume: 86,660
• 30 Day Avg. Volume: 93,375
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): 2.22
• Price to Cash Flow (P/CF): -0.70
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 1

Sintx Technologies struggles with financial and operational challenges, evident in its negative profitability and cash flow issues. The technical indicators suggest a bearish sentiment, while its valuation metrics are weak due to ongoing losses. These factors collectively contribute to a low overall stock score.

Positive Factors

Aerospace component orders

Product revenue increased significantly due to new orders for silicon nitride aerospace components.

Share repurchase

SINT announced a share repurchase plan for up to $500,000, leading to a significant increase in share price.

Negative Factors

Revenue decline

4Q24 revenue was $542K, down 39.9% y/y, below our $700K estimate.

Revenue forecasts

Revenue forecasts for 4Q24 and 2025 are maintained at levels below the previous year's estimates.

Sintx Technologies Business Overview & Revenue Model

Company Description

Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

How the Company Makes Money

Sintx Technologies generates revenue primarily through the sale of its silicon nitride ceramics products. The company's core revenue streams include the medical sector, where it provides materials for orthopedic and spinal implants, and the industrial sector, where its ceramics are used in wear-resistant and high-temperature applications. Additionally, Sintx pursues collaborative partnerships and licensing agreements with other companies to expand the applications of its technology and increase its market reach. These partnerships often involve joint development projects that can lead to new revenue opportunities. Sintx's focus on innovation and the development of new applications for its materials is a key factor in driving its earnings.

Sintx Technologies Financial Statement Overview

Summary

Sintx Technologies faces significant financial challenges, with ongoing losses and cash flow deficits despite revenue growth. The balance sheet reflects rising leverage and moderate equity levels. While there are positive signs in revenue increase and financing capabilities, substantial operational and profitability hurdles persist.

Income Statement

Sintx Technologies has shown a positive revenue growth trend from $2627k to $2887k in 2024, marking a 9.89% increase year-over-year. However, the company continues to face significant profitability issues with a gross profit margin of 71.94% but a net profit margin of -38.19%, as expenses remain high relative to revenue. The EBIT and EBITDA margins are also negative, indicating ongoing operational challenges.

Balance Sheet

The debt-to-equity ratio has increased to 1.03, suggesting rising leverage, which could pose risks amid persistent losses. The equity ratio stands at 41.36%, showing a moderate reliance on equity financing. Despite net losses, the company's liquidity remains somewhat stable, with cash and short-term investments covering more than half of its liabilities.

Cash Flow

Free cash flow remains negative, though there has been a reduction in the deficit from -$14.6M in 2023 to -$9.3M in 2024. The operating cash flow to net income ratio is negative, reflecting challenges in converting income to cash flow. Despite a positive financing cash flow, the company's ability to generate cash from operations remains a concern.

Breakdown
Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
2.89M	2.63M	601.00K	606.00K	594.00K
	Gross Profit
2.08M	1.84M	336.00K	157.00K	119.00K
	EBIT
-14.05M	-13.36M	-11.34M	-10.62M	-9.75M
	EBITDA
-14.05M	-6.60M	-11.06M	-8.63M	-6.53M
	Net Income Common Stockholders
-11.02M	-8.26M	-16.49M	-9.82M	-7.31M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
3.60M	3.34M	6.25M	14.27M	25.35M
	Total Assets
9.41M	15.37M	15.77M	21.84M	30.45M
	Total Debt
4.03M	4.25M	2.89M	2.40M	2.28M
	Net Debt
427.00K	905.00K	-3.36M	-11.88M	-23.07M
	Total Liabilities
5.52M	6.59M	10.07M	4.11M	4.64M
	Stockholders Equity
3.89M	8.77M	5.70M	17.73M	25.80M
Cash Flow		Free Cash Flow
-9.33M	-14.64M	-11.67M	-13.87M	-9.47M
	Operating Cash Flow
-8.64M	-14.12M	-10.26M	-10.13M	-9.11M
	Investing Cash Flow
-194.00K	-501.00K	-1.10M	-1.65M	1.75M
	Financing Cash Flow
9.09M	11.71M	3.34M	705.00K	30.93M

Sintx Technologies Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1.93
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SINT, the sentiment is Negative. The current price of 1.93 is below the 20-day moving average (MA) of 2.66, below the 50-day MA of 3.19, and below the 200-day MA of 3.65, indicating a bearish trend. The MACD of -0.22 indicates Positive momentum. The RSI at 36.67 is Neutral, neither overbought nor oversold. The STOCH value of 14.68 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SINT.

Sintx Technologies Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	48 Neutral	$6.36B	1.28	-45.04%	2.64%	19.24%	1.69%
CYCN	45 Neutral	$6.83M	―	-30.36%	―	―	86.52%
SNGX	43 Neutral	$6.15M	―	-248.97%	―	―	57.83%
SINT	42 Neutral	$5.23M	―	-174.07%	―	9.90%	94.56%
BTAI	39 Underperform	$9.82M	―	82.91%	―	64.20%	73.71%
BCLI	24 Underperform	$7.27M	―	234.90%	―	―	62.35%

Sintx Technologies Corporate Events

Sintx Technologies Appoints New Chairman of the Board

On March 7, 2025, SINTX Technologies, Inc. appointed Eric K. Olson as the new Chairman of the Board of Directors, succeeding B. Sonny Bal, who remains on the board. This leadership change marks a significant shift in the company’s governance structure, potentially impacting its strategic direction and stakeholder relations.